Latest revenue
$657.5M
as of 2026-03-31
Latest net income
$66.3M
as of 2026-03-31
Net margin
10.1%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $5.83B
- Enterprise value
- $5.83B
- P/E (trailing)
- 22.0×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.5%
- 52-wk high
- $581.20
- 52-wk low
- $365.20
- Beta
- —
- Shares out
- 13.3M
5-year trend
What this company does
General Chemed Corporation (the “Company” or “Chemed”) was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co. and succeeded to the business of W.R. Grace & Co.’s Special Products Group as of April 30, 1971 and remained a subsidiary of W.R. Grace & Co. until March 10, 1982. Chemed purchases, operates and divests subsidiaries engaged in diverse business activities for the purposes of maximizing shareholder value. The Company’s day to day operating businesses are managed on a decentralized basis. There are few integrated business functions between the operating units and Chemed (such as sales, marketing or purchasing). Chemed’s corporate office management participates in and…
AI summary unavailable — showing raw filing excerpt
Generated from CHE's filing dated 2026-02-27
Key risks
You should carefully consider the risks described below, together with all of the information included in this Annual Report on Form 10-K, in evaluating us and our Capital Stock. They are not the only ones facing the Company. Other risks and uncertainties not currently known to us or that we deem to be immaterial may also materially and adversely affect our business, financial condition, or results of operations. GENERAL We have incurred debt to finance the operations of the Company. The Company has debt service obligations that may restrict our operating flexibility. We cannot assure you that our cash flow from operations will be sufficient to service our debt, which may require us to…
AI summary unavailable — showing raw filing excerpt
Generated from CHE's filing dated 2026-02-27
Profitability
Operating margin
13.4%
11.3%Net margin
10.5%
15.6%Return on equity
23.7%
12.2%Return on assets
17.2%
4.7%Leverage
Debt / equity
0.37×
23.7%Long-term debt / equity
0.12×
61.0%Debt / assets
27.3%
17.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $657.5M | +1.6% | $66.3M | -7.6% | 10.1% |
Q4 2025 2025-12-31 | $639.3M | -0.1% | $76.8M | -15.0% | 12.0% |
Q3 2025 2025-09-30 | $624.9M | +3.1% | $64.2M | -15.2% | 10.3% |
Q2 2025 2025-06-30 | $618.8M | +3.8% | $52.5M | -25.9% | 8.5% |
Q1 2025 2025-03-31 | $646.9M | +9.8% | $71.8M | +10.4% | 11.1% |
Q4 2024 2024-12-31 | $640.0M | — | $90.3M | — | 14.1% |
Q3 2024 2024-09-30 | $606.2M | +7.4% | $75.8M | +1.1% | 12.5% |
Q2 2024 2024-06-30 | $595.9M | +7.6% | $70.9M | +32.8% | 11.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Home Health Care Services · SIC 8082
Your notes
Keep private notes on CHE — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$83.4K
Insider selling
$9.6M
Net activity
−$9.6M
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns CHE
Institutional value
$2.64B
Total shares held
7.7M
Distinct holders
311
-11 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.3M | $504.9M | +51.3K (+4.0%) | Added |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 815.7K | $308.1M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 636.1K | $240.3M | — | New |
| 4 | JPMORGAN CHASE & CO | 501.0K | $187.4M | -20.9K (-4.0%) | Trimmed |
| 5 | TD ASSET MANAGEMENT INC | 279.7K | $105.7M | -44.8K (-13.8%) | Trimmed |
| 6 | DIMENSIONAL FUND ADVISORS LP | 247.8K | $93.6M | +381 (+0.2%) | Added |
| 7 | FIRST TRUST ADVISORS LP | 236.4K | $89.3M | +46.8K (+24.7%) | Added |
| 8 | Boston Trust Walden Corp | 205.2K | $77.5M | — | New |
| 9 | Impax Asset Management Group plc | 176.4K | $66.6M | — | New |
| 10 | Copeland Capital Management, LLC | 148.0K | $55.9M | — | New |
| 11 | UBS Group AG | 141.9K | $53.6M | — | New |
| 12 | Invesco Ltd. | 139.2K | $52.6M | +9.6K (+7.4%) | Added |
| 13 | Bank of New York Mellon Corp | 108.3K | $40.9M | -894 (-0.8%) | Trimmed |
| 14 | Allspring Global Investments Holdings, LLC | 107.2K | $40.5M | — | New |
| 15 | VANGUARD FIDUCIARY TRUST CO | 88.2K | $33.3M | — | New |
| 16 | River Road Asset Management, LLC | 71.8K | $27.1M | — | New |
| 17 | BRIDGES INVESTMENT MANAGEMENT INC | 65.9K | $24.9M | +4.1K (+6.5%) | Added |
| 18 | FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 62.3K | $23.5M | — | New |
| 19 | JUPITER ASSET MANAGEMENT LTD | 62.0K | $23.4M | +0 (+0.0%) | No change |
| 20 | Aptus Capital Advisors, LLC | 61.1K | $23.1M | +3.7K (+6.5%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once CHE's latest filing finishes processing.